Application no. and date | 16744204.5 (espacenet) (Federated) (European Patent Register), 20160129 | Patent/reg. no. and date | DK/EP 3250610, 20230809 | Publication date | 20171206 | Priority no. and date | US 201562110071 P, 20150130, US 201562258082 P, 20151120 | EP pub. no. and date |
EP 3250610 20171206 | Effective date | | Applicant/owner | Momenta Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road
Titusville, NJ 08560, US | Applicant ref. no. | PV1690DKEP | Inventor | LING, Leona, E., 45 Fells Road
Winchester, MA 01890, US, MANNING, Anthony, 185 Hancock Street Unit 2
Cambridge, MA 02139, US, KEHRY, Marilyn, 10440 Rock Creek Drive
San Diego, CA 92131, US, KING, David, J., 310 Cole Ranch Road
Encinitas, CA 92024, US, MEADOR, James III, 38 Gryzboska Circle
Framingham, MA 01702, US, ROY, Sucharita, 20 Gabriel Ln
Acton, MA 01720, US | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , C07K 16/28 (2006.01) , G01N 33/68 (2006.01) | Title | FCRN-ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE HERAF | Int. application no. | US2016015720 | Int. publication no. | WO2016123521 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|